Since the acquisition, AbbVie has used Allergan’s aesthetics and neuroscience portfolios to diversify its revenue.
Because Allergan has been integrated into AbbVie, you can no longer buy or sell "AGN" shares directly. Instead, investors seeking exposure to Allergan's former portfolio—including and Juvederm —must now trade AbbVie stock. Investment Profile for AbbVie (ABBV) allergan stock buy or sell
: For the full year 2026, management has guided for net revenues of approximately $67 billion, representing 9.5% growth. Historical Acquisition Terms Since the acquisition